Junji Kato

42PUBLICATIONS
97CO-AUTHORS
NanomedicineMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 07, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective Study.

|Oct 01, 2025
Fusion Gene Detection in Driver Mutation-Negative Melanomas Using RNA-Based Anchored Multiplex Polymerase Chain Reaction.

Tokimasa Hida, Masashi Idogawa, Sayuri Sato

|Sep 12, 2025
Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World Multicenter Retrospective Study.

Shintaro Saito, Masahito Yasuda, Takeshi Araki

|Dec 16, 2024
The genomic landscape of cutaneous squamous cell carcinoma in Japan.

Junji Kato, Tokimasa Hida, Masashi Idogawa

|Dec 04, 2024
Single-cell profiling of acral melanoma infiltrating lymphocytes reveals a suppressive tumor microenvironment.

Tomoyuki Minowa, Kenji Murata, Yuka Mizue

|Nov 20, 2024
Genetic Characteristics of Cutaneous, Acral, and Mucosal Melanoma in Japan.

Tokimasa Hida, Masashi Idogawa, Junji Kato

Pageof 7

Frequent Collaborators

20 joint publications

Hisashi Uhara

17 joint publications

Tokimasa Hida

15 joint publications

Kohei Horimoto

10 joint publications

Masahide Sawada